Michael Weiser
Director at Iovance Biotherapeutics, Inc. (IOVA)
Michael Weiser has filed 8 insider reports with the SEC since July 2021, as director at Iovance Biotherapeutics, Inc. (IOVA). Michael Weiser made no open-market purchases or sales in the last 12 months. The latest filing, on June 18, 2026, reports grant or award at Iovance Biotherapeutics, Inc. (IOVA).
- Filings
- 8
- Companies
- 1
- Bought on market
- $68K
- Sold on market
- None
Companies where Michael Weiser is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 112,632 | $68K | $6.80 | $7.55+11% | Jun 18, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 16, 2026IOVASEC Form 4 filed by Director Weiser MichaelForm 4Grant or award
- Jun 13, 2025IOVASEC Form 4 filed by Director Weiser MichaelForm 4Grant or award
- Jun 11, 2024IOVASEC Form 4 filed by Director Weiser MichaelForm 4Grant or award
- Mar 1, 2024IOVASEC Form 4 filed by Weiser MichaelForm 4Grant or award
- Jun 6, 2023IOVASEC Form 4 filed by Weiser MichaelForm 4Grant or award
- Jun 10, 2022IOVASEC Form 4 filed by Weiser MichaelForm 4Grant or award
- May 31, 2022+$68KIOVASEC Form 4: Weiser Michael bought $67,978 worth of shares (10,000 units at $6.80), increasing direct ownership by 10% to 112,632 unitsForm 4Open-market purchase
- Jun 29, 2021IOVASEC Form 4 filed by WEISER MICHAELForm 4Grant or award
Compare Michael Weiser with
- Michael Weiser vs Frederick G Vogt1 shared
- Michael Weiser vs Daniel Gordon Kirby1 shared
- Michael Weiser vs Corleen M. Roche1 shared
- Michael Weiser vs Noah Berkowitz1 shared
- Michael Weiser vs Igor Bilinsky1 shared
- Michael Weiser vs Raj K. Puri1 shared
Other insiders at the same companies
- Frederick G VogtIOVA
- Daniel Gordon KirbyIOVA
- Corleen M. RocheIOVA
- Noah BerkowitzIOVA
- Igor BilinskyIOVA
- Raj K. PuriIOVA
- Iain D. DukesIOVA
- Athena CountouriotisIOVA
- Ryan D MaynardIOVA
- Finckenstein Friedrich GrafIOVA
- Matthew W. RosinackIOVA
- Wendy L YarnoIOVA
- Jean-Marc BelleminIOVA
Questions about Michael Weiser
- What is Michael Weiser's role at Iovance Biotherapeutics, Inc.?
- Michael Weiser reports to the SEC as director at Iovance Biotherapeutics, Inc. (IOVA), according to the latest filing on June 18, 2026.
- How many shares does Michael Weiser own?
- After the latest filing that states it, Michael Weiser directly owned 112,632 shares of Iovance Biotherapeutics, Inc. (IOVA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Weiser bought or sold stock recently?
- The most recent open-market purchase was on May 31, 2022: bought 10,000 shares of Iovance Biotherapeutics, Inc. (IOVA) for $68K at an average of $6.80.
- How do I get alerts when Michael Weiser files?
- Follow Michael Weiser on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Weiser (SEC CIK 0001221449). Totals count each trade once, skipping amendments whose original is on file, from Jul 1, 2021 on. View on SEC EDGAR